In particular, NG + CSO upregulated the expression of IL-6 and IL-10 in the serum of tumor-bearing mice and significantly increased the spleen index, suggesting that the combination of the two via nanotechnology could enhance the antitumor immune effect. The gene discussed is IL10; the disease is neoplasm.